Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company is increasing its investment in sports resources, deepening brand professionalism [5] - The company has shown stable performance despite external environmental disturbances, with a revenue of 28.676 billion RMB in 2024, a year-on-year increase of 3.9% [7] - The e-commerce channel's revenue contribution is increasing, accounting for 31% of total revenue in 2024, up 2 percentage points from 2023 [7] - The running product category has seen rapid growth, with retail sales increasing by 25% in 2024 [7] - The company is expected to achieve net profits of 2.656 billion RMB, 2.960 billion RMB, and 3.264 billion RMB for the years 2025 to 2027 respectively [7] Financial Summary - The company’s revenue forecast for 2025 is 29.164 billion RMB, with a growth rate of 1.7% [8] - The gross profit for 2025 is projected to be 13.795 billion RMB, representing 47.3% of sales revenue [8] - The net profit margin is expected to be 9.1% in 2025, with a net profit of 2.656 billion RMB [8] - The company’s total assets are projected to reach 38.366 billion RMB by 2025, with a debt ratio of 25.04% [8]

Investment Rating - The investment rating for the company is "Accumulate" [7] Core Views - In 2024, the company achieved revenue of approximately 6.54 billion, representing a year-on-year growth of 6.4%. However, net profit decreased by 11.9% to around 800 million, and attributable net profit fell by 13.3% to approximately 740 million [1] - The growth in revenue for 2024 was primarily driven by the increase in third-party business, which saw a year-on-year growth of 9.1% [1] - The company is focusing on product innovation and channel optimization to drive profit recovery, with expectations for improved profitability in the long term [5] Revenue and Profitability - The company's gross margin and net margin for 2024 were 31.3% and 12.2%, respectively, showing a decline of 0.3 percentage points and 2.6 percentage points year-on-year [2] - The revenue from related parties, third parties, and other dining customers was 1.97 billion, 4.38 billion, and 180 million, respectively, with third-party revenue growing by 8.2% [3] - The sales of hot pot base products, Chinese compound seasonings, and convenient fast food were 4.09 billion, 790 million, and 1.61 billion, respectively, with growth rates of -0.2%, +26.5%, and +15.7% [3] Product and Market Expansion - The company is implementing a "product project system" to enhance R&D efficiency and expand its B-end product matrix [5] - In 2024, the company achieved sales in 49 overseas countries and regions, further enriching its overseas market layout [5] - The company is focusing on optimizing its supply chain and enhancing market penetration through online and B-end market expansion [5] Financial Forecast and Valuation - The company is projected to achieve revenues of 7.14 billion, 7.79 billion, and 8.52 billion in 2025, 2026, and 2027, respectively, with corresponding attributable net profits of 855 million, 947 million, and 1.048 billion [6] - The expected growth rates for revenue and attributable net profit from 2024 to 2027 are 16%, 11%, and 11% [6] - The price-to-earnings ratio is projected to be 15x, 14x, and 12x for 2025, 2026, and 2027, respectively [6]

Investment Rating - The report maintains an "OUTPERFORM" rating for the company with a target price of HK$1.41, based on a current price of HK$1.26 [2][10]. Core Insights - The company reported a profit attributable to shareholders of RMB1.061 billion in 2024, a year-on-year increase of 69.49%, despite a slight decrease in operating revenue of 2.13% to RMB21.265 billion [6][10]. - The company benefits from rising potash fertilizer prices, with potash operating income decreasing from RMB5.250 billion in 2023 to RMB3.939 billion in 2024, accounting for 19% of total revenue [8][10]. - The sales of bio-fertilizers have significantly increased, with revenue share rising from 12% in 2022 to 22% in 2024, and gross profit share increasing from 14% to 36% during the same period [9][10]. Financial Performance - The company’s revenue projections for 2025-2027 are RMB22.693 billion, RMB24.979 billion, and RMB27.292 billion, respectively, with net profits expected to be RMB1.400 billion, RMB1.601 billion, and RMB1.863 billion [5][10]. - The diluted EPS is projected to increase from RMB0.20 in 2025 to RMB0.27 in 2027, reflecting a positive growth trajectory [5][10]. - The company’s gross profit margin is expected to stabilize around 12% to 12.5% over the forecast period [5][10]. Product and Business Segmentation - In 2024, the company sold 7.21 million tons of fertilizers, with compound fertilizers, phosphate fertilizers, and potash fertilizers generating revenues of RMB6.748 billion, RMB6.660 billion, and RMB3.939 billion, respectively [7][10]. - The growth business segment saw a revenue increase of 2.23% year-on-year, while the basic and production business segments experienced declines in segment profit [7][10]. Market Position and Strategy - The company is a key player in China's potash fertilizer market, acting as a negotiator for large import contracts and ensuring domestic supply [8][10]. - The strategic focus on bio-fertilizers aligns with national policies aimed at increasing efficiency and reducing chemical fertilizer usage, enhancing the company's market position [9][10].

Investment Rating - The report does not provide a specific investment rating for the company [1] Core Insights - The expansion pace of the HNB (Heated Not Burned) market in the US and UK is becoming clearer, with the company positioned as a core supplier benefiting from high growth rates [4] - The HNB industry has a long supply chain with few companies capable of integrated design and R&D, leading to high Know-How barriers and increasing patent restrictions [1][2] - The report anticipates significant growth in HNB product sales, particularly in the US market, with projections indicating a potential increase in HNB penetration to 20% by 2028 [3] Summary by Sections Company Overview - The company is recognized for its strong strategic positioning and substantial profitability in its other business segments, leading in R&D investment [2] Market Expansion - The report highlights the urgency for British American Tobacco to enhance its HNB product offerings, particularly with the anticipated launch of GLO HILO in 2024 [3][4] - The US market is crucial for British American Tobacco, contributing 44% of revenue and 54% of adjusted operating profit [3] Financial Projections - Revenue projections for 2024 to 2027 are as follows: 11,799 million, 12,011 million, 13,922 million, and 17,063 million respectively, with year-on-year growth rates of 6%, 2%, 16%, and 23% [7] - Adjusted net profit estimates for the same period are 1,303 million, 1,411 million, 2,337 million, and 3,032 million, with corresponding growth rates of -21%, 8%, 66%, and 30% [7][10] - The report projects EPS (Earnings Per Share) to increase from 0.21 in 2024 to 0.49 in 2027 [7][10]

Investment Rating - The report maintains a BUY rating for the company with a target price (TP) revised down by 9% to HK$ 25.35, implying a 36.9% upside from the current price of HK$ 18.52 [1][3]. Core Insights - The company experienced mixed performance in FY24, with net sales remaining flat at US$ 3.6 billion, while net profit decreased by 13% YoY to US$ 346 million, primarily due to higher selling expenses and fewer impairment reversals [1][2]. - Major markets such as Asia and North America saw declines of 3.6% and 1.2% YoY, respectively, but growth in Europe and Latin America offset these declines with increases of 3.1% and 17.0% YoY [1]. - The management anticipates a decline in sales for 1Q25, projecting a fall by low single digits to mid single digits, influenced by weak US consumer sentiment despite a recovery in Asia [1][9]. - Organic sales and net profit are expected to grow by 1.5% and 1.8% YoY in FY25E, respectively, supported by ongoing share buybacks and progress in dual-listing [1][9]. Financial Summary - For FY24, the company reported revenue of US$ 3,589 million, a decrease of 2.5% YoY, with a projected revenue of US$ 3,731 million for FY25E, reflecting a growth of 4.0% [2][32]. - The net profit for FY24 was US$ 346 million, down 12.9% YoY, with an expected slight recovery to US$ 351.8 million in FY25E [2][32]. - The report indicates a decline in gross profit margin from 60.0% in FY24 to an expected 59.5% in FY25E, while the operating profit margin is projected to remain at 17.1% [29][32]. Market Performance - The company's stock has seen a decline of 14.1% over the past month and 14.3% over the past three months, indicating a challenging market environment [5]. - The current market capitalization stands at HK$ 26,729.4 million, with an average turnover of HK$ 128.1 million over the last three months [3]. Shareholding Structure - Major shareholders include Schroders PLC with 6.0% and Bank of New York Mellon Corporation with 5.4% [4]. E-commerce Performance - In the first two months of FY25, online sales on major platforms like TBTM and JD.com decreased by 7% and 18% YoY, while sales on Douyin surged by 200% YoY, indicating a shift in consumer preferences and effective marketing strategies [9][15].

Investment Rating - The investment rating for the company is Neutral with a target price of HKD 20.80, representing a potential downside of 26.2% from the current price of HKD 28.20 [1][4][17]. Core Insights - The company's operational and profit growth for 2024 is under pressure, necessitating a rebalancing of its future profit structure [2]. - The core profit for 2024 is expected to be significantly below market expectations, with a forecast of HKD 4.15 billion, which is 30% lower than the previous expectations [7]. - The company has seen a 20% year-on-year decrease in residential connections, which is a major factor contributing to the lower-than-expected profitability [7]. - The retail gas volume growth for the year is projected at 2.9%, below the anticipated 5%, influenced by a warmer winter [7]. - The dividend policy appears irregular, causing confusion among investors, with a projected decline in the full-year dividend payout ratio to 52% from 2023 [7]. Financial Overview - Revenue is projected to grow from HKD 101.27 billion in 2023 to HKD 102.68 billion in 2024, reflecting a modest year-on-year growth of 1.4% [3][18]. - Net profit is expected to decline from HKD 5.22 billion in 2023 to HKD 4.09 billion in 2024, marking a significant year-on-year decrease of 21.7% [3][18]. - The earnings per share (EPS) is forecasted to remain flat at HKD 1.79 for 2024, with a slight increase to HKD 1.89 in 2025 [3][18]. - The company’s price-to-earnings (P/E) ratio is projected to decrease from 15.7 in 2023 to 14.9 in 2025, indicating a declining valuation trend [3][18]. Operational Data - The residential gas sales volume is expected to increase from 9.44 million cubic meters in 2023 to 10.04 million cubic meters in 2024, representing a growth rate of 2.9% [10]. - The company anticipates a decrease in new residential connections, with projections of 2.69 million in 2024, down from 3.37 million in 2023 [10]. - The retail gas margin is expected to slightly improve to RMB 0.54 per cubic meter by 2025 [10].

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [3]. Core Insights - The company achieved a revenue of 35.384 billion yuan in Q4 2024, representing a year-on-year growth of 8.7%, with adjusted net profit reaching 4.701 billion yuan, up 7.8% year-on-year [1][6]. - The company has successfully launched its AI model, "Keling," which has generated over 100 million yuan in revenue since its commercialization [6]. - The company continues to see healthy user engagement, with daily active users (DAU) reaching 401 million, a 4.8% increase year-on-year, and monthly active users (MAU) at 735 million, up 5.0% year-on-year [6]. Financial Data and Valuation - Total revenue projections for the company are as follows: 113.47 billion yuan in 2023, 126.90 billion yuan in 2024, and 141.54 billion yuan in 2025, with respective year-on-year growth rates of 20%, 12%, and 12% [2][10]. - Adjusted net profit is expected to be 15.335 billion yuan in 2024 and 17.327 billion yuan in 2025, with year-on-year growth rates of 140% and 13% respectively [2][10]. - The company’s return on equity (ROE) is projected to be 24.7% for 2024, with a gradual decline to 18.1% by 2027 [10]. Business Performance - The online marketing services revenue for Q4 2024 was 20.62 billion yuan, a year-on-year increase of 13.3%, although slightly below Bloomberg's consensus estimate of 15.2% [6]. - The gross merchandise volume (GMV) for Q4 2024 reached 462.094 billion yuan, reflecting a year-on-year growth of 14.4% [6]. - The company’s gross profit for Q4 2024 was 19.123 billion yuan, with a gross margin of 54.0% [6]. Future Outlook - The report indicates a downward adjustment in the projected adjusted net profit for 2025 and 2026 to 20.015 billion yuan and 22.561 billion yuan respectively, with corresponding adjusted PE ratios of 10.6x and 9.4x [6][7]. - The company is focusing on expanding its AI capabilities and has established partnerships across various sectors, including mobile manufacturing and cloud computing [6].

Investment Rating - The investment rating for WuXi Biologics is maintained as "Buy" [3] Core Views - The company reported a revenue of 18.68 billion yuan for 2024, representing a year-on-year growth of 9.6%, with a gross margin of 41.0%, an increase of 0.9 percentage points [1] - The adjusted net profit for 2024 is 4.78 billion yuan, reflecting a year-on-year increase of 1.8% [1] - The company expects accelerated growth in 2025, with projected revenue growth of 12-15% and a net profit increase of 18% [6] Financial Performance - Total revenue for 2023 was 17.05 billion yuan, with a projected increase to 21.22 billion yuan in 2025, indicating a compound annual growth rate of approximately 14% [2][8] - The net profit for 2023 was 3.4 billion yuan, with an expected rise to 3.973 billion yuan in 2025, showing a recovery trend after a slight decline in 2024 [2][8] - The company’s basic earnings per share (EPS) are projected to grow from 0.80 yuan in 2023 to 0.97 yuan in 2025 [2][9] Business Growth and Market Position - The company added 151 new projects in 2024, exceeding expectations, with over half coming from the U.S. market [6] - The North American region achieved a revenue growth of 32.5% year-on-year, despite geopolitical pressures [6] - The company’s commercial projects are expected to grow significantly, with 24 planned for 2025, up from 16 in the first half of 2024 [6] Valuation Metrics - The price-to-earnings (PE) ratio is projected to decrease from 31.3 in 2023 to 25.9 in 2025, indicating improving valuation as earnings grow [2][9] - The price-to-book (PB) ratio is expected to decline from 2.6 in 2023 to 2.2 in 2025, reflecting a more favorable valuation [2][9] Shareholder Information - The total market capitalization of WuXi Biologics is approximately 110.1 billion HKD, with major shareholder Li Ge holding a 14.28% stake [3]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 2.87 [6][4]. Core Views - The company's revenue for 2024 is projected to be USD 4.45 billion, representing a year-over-year growth of 6%, primarily driven by a recovery in server demand and the integration of Voltaira [1][3]. - The company's performance in 2H24 is expected to be impacted by a decline in smartphone connector prices and adjustments in the acoustic production line in Vietnam, leading to a revenue decrease of 1% year-over-year [2][1]. - The anticipated growth drivers for 2025 include 5G, AIoT, and audio products, with significant contributions expected from new AI server contracts and the establishment of AirPods assembly lines in India [3][4]. Summary by Sections Financial Performance - The company achieved a revenue of USD 4.20 billion in 2023, with a projected increase to USD 4.45 billion in 2024 and USD 4.70 billion in 2025, reflecting growth rates of -7.4%, 6.1%, and 5.7% respectively [5][20]. - The net profit attributable to the parent company is expected to rise from USD 128.97 million in 2023 to USD 208.76 million in 2025, with growth rates of -23.97%, 19.20%, and 35.79% [5][20]. Segment Analysis - The smartphone segment is projected to decline by 10% in 2025 due to lower connector prices, while the network equipment segment is expected to grow significantly by 55% in 2025 due to increased demand from AI server clients [11][13]. - The audio segment is anticipated to become a core revenue source in 2025, supported by the launch of new assembly lines in India [3][4]. Valuation Metrics - The target price has been adjusted to HKD 2.87, based on a 12.9x PE ratio for 2025, aligning with comparable companies [4][14]. - The company's market capitalization is reported at HKD 18.02 billion, with a closing price of HKD 2.47 as of March 28 [7][14].

Investment Rating - The investment rating for the company is maintained at "Buy" [8] Core Views - The company reported a significant increase in losses due to one-time impairments related to goodwill and automotive dealership rights, with a net loss of 2.26 billion RMB in 2024 compared to a net profit of 140 million RMB in 2023 [1][3] - The company is expected to see a significant reduction in impairment risks in 2025, leading to potential performance recovery [1][3] - The after-sales service business has shown resilience, with revenue growth of 7.1% year-on-year, indicating a strong profit foundation despite challenges in new car sales [2][3] Summary by Sections Financial Performance - The company's revenue for 2024 was 22.15 billion RMB, a decrease of 22.4% year-on-year, while the new car sales volume dropped by 14.2% to 57,000 units [2][7] - The average discount rate in the luxury car market was approximately 20.7% in 2024, impacting sales [2] - After-sales service gross margin improved by 6.4 percentage points to 60.1% in 2024, highlighting the profitability of this segment [3] Operational Strategy - The company continues to implement a low inventory turnover strategy, maintaining an inventory turnover period of 13 days, which helps mitigate larger losses during industry restructuring [4] - Early indicators for 2025 show improvements in orders and customer traffic, suggesting a positive operational outlook [4] Profit Forecast and Valuation - The projected net profits for 2025 and 2026 are 339.54 million RMB and 481.94 million RMB, respectively, with an estimated EPS of 0.26 RMB and 0.38 RMB [5][18] - The target price for the company is set at 2.09 HKD, based on a PE ratio of 7.5 for 2025 [5][9]